切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (01) : 43 -47. doi: 10.3877/cma.j.issn.1674-0807.2007.01.014

综述

植物雌激素与乳腺癌关系的研究进展
陈治1, 耿翠芝2   
  1. 1.071000 保定,河北大学附属医院普外科
    2.050011 石家庄,河北医科大学附属第四医院外一科
  • 收稿日期:2006-10-25 出版日期:2007-01-25

Advancement of the relationship between phytoestrogen and breast cancer

Zhi Chen, Cui-zhi Geng   

  • Received:2006-10-25 Published:2007-01-25
引用本文:

陈治, 耿翠芝. 植物雌激素与乳腺癌关系的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(01): 43-47.

Zhi Chen, Cui-zhi Geng. Advancement of the relationship between phytoestrogen and breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(01): 43-47.

[1]
Messina M J.Legumes and soybeans:overview of their nutritional profiles and health effects[J].Am J Clin Nutr 1999,Suppl:439S-450S.
[2]
Lamartiniere C A.Protection against breast cancer with genistein:a component of soy[J].Am J Clin Nutr,2000,Suppl:1705S-1707S.
[3]
Dai Q, Shu X O, Jin F,etal.Population-based casecontrol study of soyfood intake and breast cancer risk in Shanghai[J].Br J Cancer,2001,85:372-387.
[4]
Wu A H, Ziegler R G, Horn-Ross P L, etal.Tofu and risk of breast cancer in Asian-Americans[J].Cancer Epidemiol Biomark Prev,1996,5:901-906.
[5]
Le Bail J C, Champavier Y, Chulia A J,etal.Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells[J].Life Sci,2001,66:1281-1291.
[6]
Tang B Y,etal.Effect of equol on oestrogen receptors and on systhesis of DNA and protein in the immature rat uterus[J].J Endocrinol,1980,85(2):291.
[7]
Shutt D A.Interaction of genistein with oestradiol in the reproductive tract of the ovariectomized mouse[J].J Endocrinology,1967,37(2):231.
[8]
Lichtenstein A H.Soy protein, isoflavones and cardiovascular disease risk[J].J Nutr,1998,128(10):1589.
[9]
Alekel D L,etal.Isoflavone rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women[J].Am J Clin Nutr,2000,72(3):844.
[10]
Mousavi Y,etal.Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocareinoma human liver cancer cells and suppresses proliferation of these cells in cultures[J].Steroids,1993,58(7) :301.
[11]
Constantinou A I, Mehta R G, Vaughan A,etal.Inhibition of N-methy-N-nitrosoures-induced mammary rumors in rats by the soybean isoflavones[J].Anticancer Res,1996,16(6A) :3293 -3298.
[12]
Yanagihara K, Ito A, Toge T,etal.Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract[J].Cancer Res,1993;53(23) :5815 -5819.
[13]
Zhou J R, Grgger E T, Tanaka T, etal.Soybean phyto-chemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice [J].J Nutr,1999,129(6):1628-1635.
[14]
Peeters P H M, Keinen-Boker L, van der Schouw Y T,etal.Phytoestrogens and breast cancer risk[J].Breast Cancer Res Treat,2003,77:171 -183.
[15]
Linseisen J, Piller R, Hermann S,etal.Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study[J].Int J Cancer,2004,110(2) :284 -90.
[16]
Lu L J W, Anderson K E, Grady J J, etal.Decreased ovarian hormones during a soya diet:implications for breast cancer prevention[J].Cancer Res,2000,60:4112 -4121.
[17]
Kumar N B, Cantor A, Allen K, etal.The specific role of isoflavones on estrogen metabolism in premenopausal women[J].Cancer,2002,94:1166-1174.
[18]
Touillaud M S, Pillow P C, Jakovljevic J, etal.Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer[J].Nutr Cancer,2005,51(2):162-169.
[19]
Maskarinec G, Williams A E, Inouye J S, etal.A randomised isoflavone intervention among premenopausal women[J].Cancer Epidemiol Biomarkers Prev,2002,11:195 -201.
[20]
McMichael-Philips D F, Harding C,Morton M,etal.Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast[J].Am J Clin Nutr,1998,Suppl:1431S-1436S.
[21]
Hargreaves D F, Potten C S, Harding C,etal.Twoweek dietary soy supplementation has an estrogenic effect on normal premenopausal breast[J].J Clin Endocrinol Metab,1999,84:4017 -4024.
[22]
Key T J, Sharp G B, Appleby P N,etal.Soya foods and breast cancer risk:a prospective study in Hiroshima and Nagasaki, Japan[J].Br J Cancer,1999,81:1 24 8 - 1 25 6.
[23]
Constantinou A I, Krygier A E,Mehta R R.Genistein induces maturation of cultured human breast cancer cells and prevents tumour growth in nude mice[J].Am J Clin Nutr,1998,Suppl:1426S-1430S.
[24]
Deluca D, Krazeisen A, Breitling R,etal.Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens:comparison with other steroid metabolizing enzymes[J].J Steroid Biochem Mol Biol,2005,93(2-5) :285 -292.
[25]
Potter G A, Patterson L H, Wanogho E, etal.The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1[J].Br J Cancer,2002,86:774 -778.
[26]
Grube B J, Eng E T, Kao Y C,etal.White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation[J].J Nutri,2001,131:3288 -3293.
[27]
Le Bail J C, Champavier Y, Chulia A J, etal.Effects of phytoestrogens on aromatase, 3β and 17βhydroxysteroid dehydrogenase activities and human breast cancer cells[J].Life Sci,2000,66 (14):1281 - 1291.
[28]
Lu L J W, Cree M, Josyula S,etal.Increased urinary excretion of 2-hydroxyestrone but not 16αhydroxyestrone in premenopausal women during a soya diet containing isoflavones[J].Cancer Res,2000,60:1299 - 1305.
[29]
Banerjee S, Bueso-Ramos C, Aggarwal B B.Suppression of 7,12-dimethyl(a)anthracene-induced mammary carcinogenesis in rats by resveratrol:role of nuclear factor-κB, cyclooxygenase 2 and matrix metalloprotease 9[J].Cancer Res,2002,62:4945-4954.
[30]
Gallo D, Giacomelli S, Cantelmo F,etal.Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy[J].Breast Cancer Res Treat,2001,69:153 - 164.
[31]
Santell R C, Kieu N, Helferich W G.Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice[J].J Nutr,2000,130(7) :1665 -1669.
[32]
Lamartiniere C A, Moore J, Holland M, etal.Neonatal genistein chemoprevents mammary cancer[J].Proc Soc Exp Biol Med,1995,208:120 -123.
[33]
Murrill W B, Brown N M, Zhang J X,etal.Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats[J].Carcinogenesis,1996,17:1451 -1457.
[34]
Hilakivi-Clarke L, Onojafe I, Raygada M,etal.Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis[J].Br J Cancer,1999,80:1682 - 1688.
[35]
This P, De la Rochefordière A, Clough K, etal.Phytoestrogens after breast cancer[J].Endocr Relat Cancer,2001,8:129 -134.
[36]
Messina M J, Loprinzi C L.Soy for breast cancer survivors:a critical review of the literature[J].J Nutr,2001,131:3095.
[37]
Ju Y H, Doerge D R, Allred K F, etal.Dietary genistein negates the ihibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer(MCF-7) cells implanted in athymic mice[J].Cancer Res,2002,62:2474 -2477.
[38]
Schwartz J A, Liu G, Brooks S C.Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-induced genes[J].Biochem Biophy Res Commun,1998,253:38 -43.
[39]
Tanos V, Brzezinski A, Drize O,etal.Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro[J].Eur J Obstet Gynecol Reprod Biol,2002,102:188-194.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[5] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[6] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[7] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[8] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[9] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[10] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[11] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[14] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
[15] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 基于自动乳腺超声的列线图模型早期预测HER-2阳性乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 355-362.
阅读次数
全文


摘要